anonymous
Guest
anonymous
Guest
Hearing from multiple Janssen divisions that changes are coming (again). All of pharm is now under J&J Innovative Medicine and many divisions struggling, including CVM. Anyone have any insights on the validity of the rumors? Anyone have a timeline?